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(R) were defined as patients with improvement of one or more NYHA func-
tional class, with a significant improvement in quality of life and without epi-
sode nor hospitalization for heart failure during follow-up.
Results:  34% of the patients constitute the non-responder group (NR). No
difference between R and NR was observed in LVEF, QRS width, NYHA,
cardiovascular risk factors nor drug medication. Non-ischaemic dilated cardi-
omyopathy was significantly more present in R (71% vs 27%; p=0.03). Before
CRT, NR had more important left ventricular end-diatolic diameter, left ven-
tricular end-systolic diameter  and  more elevated left pressions.  Atrioventric-
ular dyssynchrony was significantly more observed in R (66% vs 9%;
p=0.006) so as intraventricular dyssynchrony (95% vs 27%; p=0.001).BNP is
significantly more elevated in NR (602± 385 vs 320± 361; p=0.03) before
CRT.After 3 and 6 month, a significant decrease in left ventricular end-diatolic
and end-systolic diameters, LVEF and normalisation of left and right pressions
occur in R. Likewise,  BNP levels were lower in R.  
Conclusions: NR patients have before implantation a more severe cardi-
omyopathy. At follow-up, left ventricular remodelling could only be observed
in R patients. These data suggest that cardiac CRT should not be proposed too
late so that left ventricular remodelling could be expected.
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Background: Cardiac Resynchronization Therapy (CRT) is associated
with reverse left ventricular (LV) remodeling. However, the effects of CRT
induced mechanical remodeling on electrical remodeling, and the occurrence
of ventricular arrhythmias has not been clearly established.
Objectives: We studied the relationship between mechanical remodeling,
electrical remodeling and the occurrence of appropriate implantable cardio-
verter defibrillator (ICD) therapy one year after CRT.
Methods: We analyzed data from 45 patients who underwent ICD-CRT
implantation at our center. Patients had New York Heart Association (NYHA)
functional class III or IV heart failure symptoms, left ventricular ejection frac-
tion (LVEF) 35%, and QRS duration 120 ms or QRS <120ms with left intra-
ventricular dyssynchrony. Significant LV reverse remodeling was defined by
a minimum 10% decrease in the LV end diastolic diameter (LVEDd) at one
year of follow-up. Electrocardiographic indices of dispersion of repolarization
(DR) (QTc, Tpeak-Tend (Tp-e) and their dispersion) were measured immedi-
ately and one year post-CRT implantation. The occurrence of appropriate ICD
therapy was noted for each patient.
Results: Patients with (n=21) and without (n=24) significant LV reverse
remodeling had similar baseline characteristics. At one year of follow-up,
patients with reverse LV  remodeling exhibited both a significant decrease in
DR parameters and a lower rate of ICD therapy (p=0.0025).
Conclusion: Reverse LV mechanical remodeling is associated with
reversal of electrical remodeling and a lower rate of appropriate ICD therapy
following CRT.
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Introduction: post-ischemic electrical storm (PIES) occurring shortly after
the acute phase of myocardial infarction (MI) is a rare but potentially lethal
phenomenon. Clinical and therapeutic options are poorly known.  
Methods: 14 pts (12 men, 61 ± 13 years old) underwent RF ablation for
intractable PIES. PIES occurred 10 ± 5 days after MI (4 months in one pt).
Mean EF was 28 ± 7 %. Fast monomorphic VT (10 pts), FV (8 pts) or torsades
de pointes (5 pts) recurred in each pt despite maximal anti-arrhythmic therapy
(mean 22 ± 13 episodes). MI was inaugural anterior MI in each but 3 pts (sub-
endocardial in 2, inferior in 1), with one vessel disease (left descending artery)
in 8 pts (2 or 3 vessels in 6). When performed (4 pts), new PTCA did not con-
trol PIES. RF ablation was performed as a last chance solution, targetting ven-
tricular premature beats arising from the left septal Purkinje network (in all
patients the arrhythmia was of Purkinje origin, defined by a sharp spike
Purkinje-potential preceding ventricular activation during sinus rhythm as well
as during arrhythmia).
Results: Abolition of Purkinje potentials and of Purkinje premature beats
led to resumption of electrical storm in 12/14 pts with 1 procedure (2 in one
pt). The two pts with unsuccessful RF ablation died within a few hours from
intractable heart failure and recurring arrhythmias. All other pts were
implanted with an ICD (two pts had already been implanted before). During a
18 ± 19 months follow-up, 3 pts present with recurring isolated VT episodes
found in ICD memories. Seven pts died from cardiac or non cardiac causes (7
± 10 months).
Conclusions:  PIES is a rare but potentially lethal event occurring mainly
in inaugural large anterior acute MI. RF ablation of initiating Purkinje-prema-
ture beats may be an efficient therapeutic solution despite the poor long-term
prognosis of such patients.
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Introduction: Monomorphic sustained ventricular tachycardia (MSVT) in
structural heart disease (SHD) carries poor prognosis and usually needs ICD
implantation. Whether successful RF ablation of VT in this setting could avoid
the need of ICD implantation is largely unknown.
Methods: 105 successive with SHD (88 men, age 64 ± 16) were followed
after RF ablation of MSVT. An ICD was not implanted either because of end
stage extra cardiac pathology, advanced age or well-tolerated MSVT and pre-
served EF. 33 % were on amiodarone and 51 % on beta-blockers.
Results: 128 procedures were performed (1,2/pt) in 4 centers. Coronary
artery disease was present in 54%, right ventricular dysplasia in 10 %, dilated
cardiomyopathy in 10 % and various SHD in 26 %. Mean EF was 48 ± 12 %
(14 % with EF < 0,35). VT was well tolerated in 77 % (169 ± 32 bpm) with
syncope or near-syncope in 23 %. 11 % presented with electrical storm. Abla-
tion was performed using various techniques and end points. Complete acute
success was considered achieved in 80 % and undetermined in 5 pts. Not any
VT was induced in 92 % at the end of the procedure. Complications were arte-
rial dissection/occlusion (2 pts), tamponnade (1 pt), AV block (1 pt) and
hematomas (4 pts). Patients were discharged on beta-blockers (63%) and ami-
odarone (29%). Mean follow-up was 21 ± 16 months. VT recurred in 14 % (7
± 5 months) without compromise of the vital status. Mortality rate was 11 %
(no SD) (16 ± 15 months). Additional RF ablations were performed again in
14 pts with recurring VT and VT further recurred in 4 while SD occurred in
2.  Final VT recurrence rate including redo precedures was 14 %.  An ICD
was finally implanted in 5 pts. There was no difference in VT recurrence rate
according to the cardiopathy, clinical variables, EF, VT rate and tolerance or
to residual VT inducibility.
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Conclusions: RF ablation for VT occurring in pts with SHD without ICD
appears safe and efficient and might be now proposed as an alternative for
ICD implantation because of associated morbidity, advanced age or when VT
is well tolerated and does not occur in the context of advanced heart disease.
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Background: New transvenous devices using cryoenergy have been
recently introduced to perform pulmonary vein isolation (PVI) for the treat-
ment of atrial fibrillation (AF). Experimental data suggested that cryoenergy
(CRYO) produced less endothelial disruption and platelet activation than
radiofrequency energy (RF) offering safety benefits. We aimed to compare
both systems with regards to safety in patients by measuring for the first time
sensitive laboratory markers of cell damage. platelet activation and inflamma-
tion after a PVI using either one of those energies.
Methods: Sixty patients with symptomatic drug-resistant AF referred for
PVI (56±9 years of age, 48 males. 38 with paroxysmal and 22 with persistent
AF) were randomly assigned to undergo the ablation procedure using either an
open irrigated tip RF catheter (Thermocool®. Biosense Webster) or a cryobal-
loon catheter (Arctic front®. Medtronic). Systemic markers of cell damage
(procoagulant microparticles [MPs of various cellular origin], troponin T, CK
and CK-MB). platelet activation (ADP-induced light transmittance aggrega-
tion [LTA], expression of the platelet surface proteins P-selectin [pSEL] and
activated GPIIb/IIIa [PAC-1]) and inflammatory response (hs-CRP) were
determined frequently before and 4, 24 and 48 hours  after the procedure.
Results: Procedure time was significantly shorter in patients treated with
the cryoballoon (177±30 min versus 200±46 min. p=0.028), but there were no
differences in fluoroscopic time, clinical event rate and success rate.  Post-pro-
cedural increases of MPs Troponin T and hs-CRP were observed but there
were no consistent differences in parameters used for comparative laboratory
safety assessment of the ablation systems using either cryoenergy or radiofre-
quency energy.
Conclusions: Neither systematic sensitive markers of cell damage, of
platelet activation nor of inflammatory response could detect any difference in
the safety profile between cryoenergy and RF energy used for transseptal PVI
in patients with AF.
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Introduction: Radiofrequency (RF) catheter ablation has emerged as an
effective treatment for patients with drug-refractory atrial fibrillation (AF).
The objective of this study is to evaluate the efficacy and safety of pulmonary
vein isolation (PVI) with a cryoballoon catheter (Arctic Front, Cryocath,
Quebec, Canada). 
Methods: In 44 consecutive patients with symptomatic paroxysmal AF (28
males, age 57+/-11 years), circumferential PVI was performed using a cry-
oballoon catheter. Before discharge, all patients were subjected to 24-hour
Holter electrocardiograms, echocardiography, and esophageal endoscopy.
Magnetic resonance imaging was performed prior to and 3 months after abla-
tion.  At a mean follow up of 4.3 +/- 1.2 months after ablation, patients under-
went clinical review and 24-hour Holter electrocardiograms. Clinical and
demographic variables were analyzed via logistic regression to assess for pre-
dictors of recurrence. 
Results: Thirty-two of the 44 patients (73%) had complete isolation of all
PVs.  Out of 176 treated veins, 164 were completely isolated (93%). The
number of balloon applications per vein was 2.3 ± 0.8. The mean procedure
and fluoroscopy times were 163.4 ± 36.2 and 32.0 ± 11.7 min, respectively.
Eight patients had evidence of mild pericardial effusions requiring no further
treatment.  Five patients (11.4%) experienced phrenic nerve palsy, 4 of which
resolved immediately and one at 2 weeks.  Follow up at 4.3 +/- 1.2 months
showed freedom from AF in 28 patients (63.6%) and freedom from AF
without antiarrhythmic drug therapy in 19 patients (43.2%).  Of all clinical
variables analyzed, only early recurrence of AF within 4 days post ablation
was associated with long term AF recurrence (p= 0.002; OR= 0.11; CI=
[0.018-0.524]). 
Conclusion: PVI can be safely achieved with the cryoballoon catheter with
a moderate success rate at 4.3 months follow-up. Early recurrence of AF
seems to be a clinical predictor for long term atrial fibrillation recurrence.
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Background: Radiofrequency ablation [RFA] of outflow tract ventricular
ectopic beats [OTVEBs] can be performed using either a 4 mm or an exter-
nally-cooled tip RFA catheter but not data are available concerning the safety
and the efficacy with a large-tip [8 mm] catheter. However, experimental and
clinical studies suggest that the efficacy of catheters may vary mainly with
several parameters including catheter tip, cooling effect, anatomy and catheters
orientation. We hypothesized that an 8mm tip catheter can be safely used in
patients with OTVEBs. 
Objectives: The aim of this prospective study was to evaluate the safety
and the efficacy of an 8mm tip catheter in patients with OTVEBs. 
Method and Results: Between September 2008 and March 2010, 17
patients were referred for RFA of symptomatic OTVEBs and 2 patients were
excluded [1 cardiomyopathy and 1 due to the vicinity of His bundle]. In a pri-
mary intent the 8mm tip catheter was tested. Population characteristics were as
follows: mean age of 51±17 years; 46.7% female; LVEF (55±8%); VEB mor-
phology [100% LBBB], axis [13 inferior and 2 superior], major symptoms
[palpitations in 7, pre-syncope in 6, syncope in 1, and dyspnea in 1], VEB
width 144±21 ms, and number of drug failure [2.2±0.5]. RFA succeeded
in 14/15 patients [93.3%] and RFA parameters were: procedure time [94±35
min], duration of application [11±10 min], impedance [81±12 ], temperature
[48±5 degree] and power [46±17 watts]. In one patient RFA failed. Recur-
rence occurred in 1/15 patients [6.6%] with a mean follow-up of 8±6 months.
No complication was observed. 
Conclusions: This study demonstrated the feasibility, safety and efficacy
of a strategy with an 8mm tip RFA catheter to cure patients with outflow tract
ventricular ectopic beats.
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